Skip to main content
letter
. 2015 Feb 1;191(3):352–355. doi: 10.1164/rccm.201408-1480LE

Table 2.

TSC1 and TSC2 Loss of Heterozygosity and Mutations in Cancer

Cancer Tissue* TSC1 Loss of Heterozygosity
TSC1 Mutation
TSC2 Loss of Heterozygosity
TSC2 Mutation
Samples (n) Loss of Heterozygosity [n (%)] Samples (n) Mutated Samples [n (%)] Samples (n) Loss of Heterozygosity [n (%)] Samples (n) Mutated Samples (%)
Lung 476 139 (29.2) 1,184 19 (1.6) 476 92 (19.3) 1,183 20 (1.7)
Breast 852 138 (16.2) 1,174 8 (0.7) 852 56 (6.6) 1,174 6 (0.5)
CNS 638 45 (7.1) 1,231 4 (0.3) 638 49 (7.7) 1,232 14 (1.1)
Endometrium 246 35 (14.2) 271 14 (5.2) 246 19 (7.7) 271 17 (6.3)
Kidney 435 87 (20.0) 911 11 (1.2) 435 29 (6.7) 847 20 (2.4)
Large intestine 540 36 (6.7) 723 30 (4.1) 540 20 (3.7) 723 31 (4.3)
Ovary 462 159 (34.4) 577 5 (0.9) 462 159 (34.4) 610 5 (0.8)

Definition of abbreviation: CNS = central nervous system.

*

Data are collected from catalog of somatic mutations in cancer database (14).